PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
31-Jan-2024 AlzeCure CEO Martin Jönsson to Present at the International Investor Conference BioCapitalEurope AccessWire
31-Jan-2024 Larodan Partners With Bioz to Provide Researchers With Scientific Product Validation AccessWire
31-Jan-2024 IRLAB: Invitation to the Year-end Report 2023 Presentation and Webcast AccessWire
31-Jan-2024 Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand AccessWire
30-Jan-2024 AlayaCare Joins AWS Public Sector Partner Program AccessWire
30-Jan-2024 Andover Endodontist Dr Julie Saviano Joins Woburn Dentistry AccessWire
30-Jan-2024 VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial AccessWire
30-Jan-2024 Adolore BioTherapeutics to Present at the 5th Annual National Institutes of Health (NIH) HEAL Initiative Scientific Meeting AccessWire
30-Jan-2024 Introducing Fortifeye Fit Pro AccessWire
30-Jan-2024 Diana Shuster, PhD, Joins CenExel as Vice President of Clinical Sciences AccessWire
30-Jan-2024 Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Study Indicates Psychoactive Activity of Medicinal Plant Utilized for Centuries by Indigenous Peoples in Tropical Regions AccessWire
30-Jan-2024 Lexaria's Submits Investigational New Drug Application AccessWire
30-Jan-2024 From the Margins: Gilead’s Book Uniquely Captures What It’s Like To Be Marginalized by Disease AccessWire
30-Jan-2024 CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S. AccessWire
30-Jan-2024 Physicians Shift 2024 Tech Investments to Robust Practice Management Platforms With AI, Analytics and Value-Based Care Support Tools, Black Book Survey AccessWire
30-Jan-2024 Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference AccessWire
30-Jan-2024 MorphoSys Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and Reduces Financial Liability AccessWire
30-Jan-2024 MindBio Therapeutics Nears Completion of Landmark Phase 2a LSD Microdosing (MB22001) Clinical Trial in Depressed Patients AccessWire
30-Jan-2024 BioNxt Solutions Announces Closing of Final Tranche of Non-Brokered Private Placement AccessWire
30-Jan-2024 CNS Pharmaceuticals Announces Pricing of $4.0 Million Public Offering AccessWire